Moderna Dirección
Dirección controles de criterios 3/4
El CEO de Moderna es Stephane Bancel , nombrado en Oct 2011, tiene una permanencia de 13.08 años. compensación anual total es $17.07M, compuesta por 9.2% salario y 90.8% primas, incluidas acciones y opciones de la empresa. posee directamente un 5.48% de las acciones de la empresa, por valor de $902.12M. La antigüedad media del equipo directivo y de la junta directiva es de 4.6 años y 10.5 años, respectivamente.
Información clave
Stephane Bancel
Chief Executive Officer (CEO)
US$17.1m
Compensación total
| Porcentaje del salario del CEO | 9.2% |
| Permanencia del CEO | 13.1yrs |
| Participación del CEO | 5.5% |
| Permanencia media de la dirección | 4.6yrs |
| Promedio de permanencia en la Junta Directiva | 10.5yrs |
Actualizaciones recientes de la dirección
Recent updates
Moderna: Assessing The Impact Of GSK's Patent Lawsuit
Oct 22The Market Doesn't Like What It Sees From Moderna, Inc.'s (NASDAQ:MRNA) Revenues Yet As Shares Tumble 28%
Oct 11
Moderna: Still Bullish View
Sep 20Moderna: Fresh Sell-Off On Cost Cutting Initiatives, Short-Term Outlook Troubling
Sep 12Moderna's Vaccine Progress Undermined By RSV Market Contraction (Rating Downgrade)
Aug 26Lacklustre Performance Is Driving Moderna, Inc.'s (NASDAQ:MRNA) 28% Price Drop
Aug 18Analysts Have Lowered Expectations For Moderna, Inc. (NASDAQ:MRNA) After Its Latest Results
Aug 03Moderna: State Of Play Ahead Of Q2 Earnings, I'm (Temporarily) Pessimistic
Jul 30Moderna: Really Strong Competition
Jun 30Moment Of Truth Approaches For Moderna's RSV Vaccine
Jun 18What Moderna, Inc.'s (NASDAQ:MRNA) 27% Share Price Gain Is Not Telling You
Jun 06Moderna: Betting On Bird Flu Rally Is A Poor Strategy For A Value Investor
May 23Moderna Q1: A Promising Pipeline Is Undervalued
May 15We Discuss Why Moderna, Inc.'s (NASDAQ:MRNA) CEO Compensation May Be Closely Reviewed
Apr 30Moderna, Inc.'s (NASDAQ:MRNA) Prospects Need A Boost To Lift Shares
Apr 22Moderna: Considering The Cancer Vaccine Angle
Apr 11Moderna Continues To Build A Pipeline
Apr 03Lukewarm Reaction To Moderna's Vaccine Day Sums Up Fine Margins In Play
Mar 27Moderna, Inc. (NASDAQ:MRNA) Just Released Its Yearly Results And Analysts Are Updating Their Estimates
Feb 27Moderna: Counting On Pipeline Too Much
Feb 23Análisis de compensación del CEO
| Fecha | Compensación total | Salario | Ingresos de la empresa |
|---|---|---|---|
| Sep 30 2024 | n/a | n/a | -US$2b |
| Jun 30 2024 | n/a | n/a | -US$6b |
| Mar 31 2024 | n/a | n/a | -US$6b |
| Dec 31 2023 | US$17m | US$2m | -US$5b |
| Sep 30 2023 | n/a | n/a | -US$3b |
| Jun 30 2023 | n/a | n/a | US$1b |
| Mar 31 2023 | n/a | n/a | US$5b |
| Dec 31 2022 | US$19m | US$1m | US$8b |
| Sep 30 2022 | n/a | n/a | US$12b |
| Jun 30 2022 | n/a | n/a | US$14b |
| Mar 31 2022 | n/a | n/a | US$15b |
| Dec 31 2021 | US$18m | US$990k | US$12b |
| Sep 30 2021 | n/a | n/a | US$7b |
| Jun 30 2021 | n/a | n/a | US$3b |
| Mar 31 2021 | n/a | n/a | US$598m |
| Dec 31 2020 | US$13m | US$946k | -US$747m |
| Sep 30 2020 | n/a | n/a | -US$597m |
| Jun 30 2020 | n/a | n/a | -US$488m |
| Mar 31 2020 | n/a | n/a | -US$505m |
| Dec 31 2019 | US$9m | US$921k | -US$514m |
| Sep 30 2019 | n/a | n/a | -US$535m |
| Jun 30 2019 | n/a | n/a | -US$499m |
| Mar 31 2019 | n/a | n/a | -US$459m |
| Dec 31 2018 | US$59m | US$863k | -US$402m |
| Sep 30 2018 | n/a | n/a | -US$299m |
| Jun 30 2018 | n/a | n/a | -US$280m |
| Mar 31 2018 | n/a | n/a | -US$266m |
| Dec 31 2017 | US$7m | US$651k | -US$270m |
Compensación vs. Mercado: La compensación total de Stephane($USD17.07M) está por encima de la media de empresas de tamaño similar en el mercado US ($USD12.73M).
Compensación vs. Ingresos: La compensación de Stephane ha sido consistente con los resultados de la empresa en el último año.
CEO
Stephane Bancel (51 yo)
13.1yrs
Permanencia
US$17,068,514
Compensación
Mr. Stephane Bancel serves as Board Director of Indigo Agriculture Inc since 2020. Mr Bancel served as Interim President of Valera LLC. He serves as CEO and Director at Valera LLC.Mr. Bancel serves as a S...
Equipo directivo
| Nombre | Posición | Permanencia | Compensación | Propiedad |
|---|---|---|---|---|
| CEO & Director | 13.1yrs | US$17.07m | 5.48% $ 902.1m | |
| President | no data | US$7.34m | 0.42% $ 68.4m | |
| Chief Financial Officer | 2.2yrs | US$4.32m | 0.0025% $ 406.3k | |
| Chief Legal Officer & Corporate Secretary | 3.4yrs | US$4.31m | 0.0047% $ 776.5k | |
| Chief Technical Operations & Quality Officer | 1.8yrs | sin datos | sin datos | |
| Chief Information Officer | 1.8yrs | sin datos | sin datos | |
| Senior VP & Head of Investor Relations | 5.6yrs | sin datos | sin datos | |
| Senior Director of Corporate Communications | no data | sin datos | sin datos | |
| Chief Human Resources Officer | 5.1yrs | sin datos | sin datos | |
| Chief Development Officer | 4.8yrs | sin datos | sin datos | |
| Chief Data & AI Officer | no data | sin datos | sin datos | |
| Senior VP & Head of Global Regulatory Science | 4.6yrs | sin datos | sin datos |
4.6yrs
Permanencia media
51yo
Promedio de edad
Equipo directivo experimentado: El equipo directivo de MRNA se considera experimentado (4.6 años antigüedad media).
Miembros de la Junta
| Nombre | Posición | Permanencia | Compensación | Propiedad |
|---|---|---|---|---|
| CEO & Director | 13.7yrs | US$17.07m | 5.48% $ 902.1m | |
| Co-Founder | 14.8yrs | US$663.52k | 0.58% $ 95.1m | |
| Independent Director | 4.3yrs | US$481.27k | 0.00018% $ 29.6k | |
| Member of Scientific Advisory Board | no data | US$461.27k | 2.99% $ 492.0m | |
| Member of Technology Advisory Board | 10.5yrs | sin datos | sin datos | |
| Independent Director | 3.7yrs | US$476.25k | 0.00055% $ 90.5k | |
| Member of Technology Advisory Board | 10.5yrs | sin datos | sin datos | |
| Independent Non Executive Director | 4.9yrs | US$481.27k | 0.0054% $ 881.8k | |
| Member of Technology Advisory Board | 10.5yrs | sin datos | sin datos | |
| Member of Scientific Advisory Board | no data | sin datos | sin datos | |
| Chairman of Scientific Advisory Board | 10.5yrs | sin datos | sin datos | |
| Member of Technology Advisory Board | 10.5yrs | sin datos | sin datos |
10.5yrs
Permanencia media
65yo
Promedio de edad
Junta con experiencia: Los miembros de la junta directiva de MRNA son experimentados ( 10.5 años antigüedad media).